Results 1 to 10 of about 429,144 (355)

The Pharmacological Basis of Therapeutics [PDF]

Anesthesiology, 1971
It is with great pleasure that I received the fifth edition of this unique book. At the time of its publication, the first edition was the best and most useful text in English for the teaching of pharmacology; the current edition demonstrates the editors' ability to define and meet, in a continually innovative fashion, the physician's needs.
Howard L. Zauder
openalex   +4 more sources

History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications

Frontiers in Physiology, 2021
Mathematical biology and pharmacology models have a long and rich history in the fields of medicine and physiology, impacting our understanding of disease mechanisms and the development of novel therapeutics.
Benedetto Piccoli, Susana Neves-zaph, Rosario Lombardo   +2 more
exaly   +3 more sources

TB and HIV Therapeutics: Pharmacology Research Priorities [PDF]

AIDS Research and Treatment, 2012
An unprecedented number of investigational drugs are in the development pipeline for the treatment of tuberculosis. Among patients with tuberculosis, co-infection with HIV is common, and concurrent treatment of tuberculosis and HIV is now the standard ...
Kelly E. Dooley, Peter S. Kim, Sharon D. Williams, Richard Hafner   +3 more
doaj   +2 more sources

Pharmacology and Therapeutics in Pakistan [PDF]

Nature, 1964
Syed Mohd Abbas Zaidi
openalex   +5 more sources

Clinical pharmacology and therapeutics [PDF]

Postgraduate Medical Journal, 1991
Richard Horton, M. J. Kendall
openalex   +6 more sources

Pharmacology and Therapeutics.

BMJ, 1965

openalex   +3 more sources

Educating Medical Students on How to Prescribe Anti-Hyperglycaemic Drugs: A Practical Guide

Diabetology, 2023
In the light of the rapidly increasing global incidence of, and therapeutic arsenal for, diabetes type 2, this brief report underscores the need for advancements in clinical pharmacology and therapeutics (CPT) education with regard to diabetes type 2. We
Erik M. Donker, Andrej Belančić, Joost D. Piët, Dinko Vitezić, Jelle Tichelaar, on behalf of the Clinical Pharmacology and Therapeutics Teach the Teacher (CP4T) Program and the Early Career Pharmacologists of the European Association for Clinical Pharmacology and Therapeutics (EACPT)   +5 more
doaj   +1 more source

Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study

Journal of Diabetes Research, 2022
Aims. This study is aimed at clarifying the relationship between visit-to-visit variability of glycated hemoglobin (HbA1c) and the risk of diabetic kidney disease (DKD) and to identifying the most useful index of visit-to-visit variability of HbA1c ...
Yunyi Yan, Nozomi Kondo, Kentaro Oniki, Hiroshi Watanabe, Tadashi Imafuku, Yuki Sakamoto, Takuro Shigaki, Akari Maruyama, Hitomi Nakazawa, Tetsuya Kaneko, Ayami Morita, Akira Yoshida, Hitoshi Maeda, Toru Maruyama, Hideaki Jinnouchi, Junji Saruwatari   +15 more
doaj   +1 more source

Phytochemical Analysis, Acute Toxicity, as well as Antihyperglycemic and Antidiabetic Activities of Corchorus olitorius L. Leaf Extracts

The Scientific World Journal, 2022
Backgroundand Aim. Diabetes mellitus is a metabolic disorder that has no known cure with continuous endeavors to find a therapy for the condition. According to some studies, traditional leafy vegetables could prevent and manage diabetes by modifying the ...
Rebecca Nakaziba, Aloysius Lubega, Jasper Ogwal-Okeng, Paul E. Alele   +3 more
doaj   +1 more source

Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID‐19

Clinical and Translational Science, 2020
The global response to finding therapeutics for coronavirus disease 2019 (COVID‐19) is chaotic even if well intentioned. There is an opportunity, but more importantly, an obligation for the global clinical and quantitative pharmacology community to come ...
Dan Hartman, Steven Kern, Fran Brown, Suzanne K. Minton, Craig R. Rayner   +4 more
doaj   +1 more source